Literature DB >> 12357799

One pot/two donors/one diol give one differentiated trisaccharide: powerful evidence for reciprocal donor-acceptor selectivity (RDAS).

Bert Fraser-Reid1, J Cristóbal López, K V Radhakrishnan, M V Nandakumar, Ana M Gómez, Clara Uriel.   

Abstract

Three component, one-pot reactions involving equimolar amounts of the acceptor diol and both armed and disarmed donors presented simultaneously, produce a single double-differential glycosidation product; this phenomenon provides evidence for Reciprocal Donor Acceptor Selectivity (RDAS).

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12357799     DOI： 10.1039/b206598c

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  5 in total

Review 1.  Automated Chemical Oligosaccharide Synthesis: Novel Approach to Traditional Challenges.

Authors:  Matteo Panza; Salvatore G Pistorio; Keith J Stine; Alexei V Demchenko
Journal:  Chem Rev       Date:  2018-06-28       Impact factor: 60.622

Review 2.  Synthesis and Glycosidation of Anomeric Halides: Evolution from Early Studies to Modern Methods of the 21st Century.

Authors:  Yashapal Singh; Scott A Geringer; Alexei V Demchenko
Journal:  Chem Rev       Date:  2022-06-08       Impact factor: 72.087

3.  Conformationally superarmed S-ethyl glycosyl donors as effective building blocks for chemoselective oligosaccharide synthesis in one pot.

Authors:  Mithila D Bandara; Jagodige P Yasomanee; Nigam P Rath; Christian M Pedersen; Mikael Bols; Alexei V Demchenko
Journal:  Org Biomol Chem       Date:  2017-01-18       Impact factor: 3.876

4.  Thio-arylglycosides with various aglycon para-substituents: a probe for studying chemical glycosylation reactions.

Authors:  Xiaoning Li; Lijun Huang; Xiche Hu; Xuefei Huang
Journal:  Org Biomol Chem       Date:  2008-10-20       Impact factor: 3.876

5.  Application of the superarmed glycosyl donor to chemoselective oligosaccharide synthesis.

Authors:  Laurel K Mydock; Alexei V Demchenko
Journal:  Org Lett       Date:  2008-05-01       Impact factor: 6.005
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.